Abraxis BioScience Names Mary Lynne Hedley, Ph.D., Executive Vice President of Operations and Chief Scientific Officer

14-Jul-2009 - USA

Abraxis BioScience, Inc. announced that Mary Lynne Hedley, Ph.D. has been appointed Executive Vice President of Operations and Chief Scientific Officer.

Dr. Hedley most recently served as Executive Vice President of Eisai Corporation of North America following Eisai’s acquisition of MGI PHARMA, INC. where she had served as Executive Vice President and Chief Scientific Officer since 2005. She joined MGI PHARMA in 2004 as Senior Vice President and General Manager. Previously, Dr. Hedley co-founded ZYCOS, Inc., a biotechnology company, and held roles of progressively greater responsibility ultimately leading to her serving as the company’s President and Chief Executive Officer.

Dr. Hedley’s early research career consisted of two consecutive postdoctoral fellowships at Harvard University from 1989 through 1996. She earned her bachelor of science degree in Microbiology from Purdue University and her doctorate degree in Immunology from the University of Texas, Southwestern Medical Center. She is a named inventor on multiple patents in the field of immunology, and has been widely published in a variety of peer-reviewed journals. Dr. Hedley is the recipient of multiple awards and fellowships, is a frequent guest lecturer, and an active volunteer in educational as well as local community organizations.

Other news from the department people

More news from our other portals

All FT-IR spectrometer manufacturers at a glance